Lake Street analyst Frank Takkinen reiterated a Buy rating on TELA Bio today and set a price target of $6.00. Takkinen covers the Healthcare sector, focusing on stocks such as Sight Sciences, ...
Two men charged over 'mistaken identity' street execution of innocent plumber gunned down outside Sydney home. Reeves facing revolt over income tax raid that will hit NHS and teachers BBC ‘100% fake ...
Hosted on MSN
Is Palantir Wall Street's Next Stock Split?
Some investors are speculating that Palantir will announce a stock split with its earnings on Nov. 3. The company's stock has risen more than 330% in the last year alone. 10 stocks we like better than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback